Illumina to divest Grail within a year if it does not win challenge in EU court

Illumina hit with record $476 million EU antitrust fine over Grail deal

Illumina asks appeals court to undo FTC ruling that it must sell subsidiary

Grail says about 400 patients incorrectly informed they may have cancer